Opthea Limited (AU:OPT) has released an update.
Opthea Limited has launched a fully underwritten Retail Entitlement Offer to raise approximately A$55.0 million, opening on June 19, 2024, and closing on July 10, 2024. The offer, part of a larger capital raise that included institutional investors, aims to fund the clinical development of sozinibercept for wet AMD. Participants will also receive options on a 1 for 3 basis upon issuance of the new shares, with the options being listed on the ASX.
For further insights into AU:OPT stock, check out TipRanks’ Stock Analysis page.
